APT Competitors or Alternatives

APT's top competitors include Cidara, Seres Therapeutics and Axial Therapeutics.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

APT's company profile

Ian Hardy

Interim-CEO

- -
1 - 25
$107.5M
$100K - 5M
1
APT's Competitor - Cidara logo

Jeffrey Stein

President & CEO

89/100
90
$510.8M
$1.3M
2
APT's Competitor - Seres Therapeutics logo

Eric D. Shaff

President & CEO

87/100
330
$617.9M
$126.3M
3
APT's Competitor - Axial Therapeutics logo

Stewart A. Campbell

CEO

86/100
25 - 100
$130.1M
$5M - 25M
4
APT's Competitor - Skunk logo

CEO

- -
25 - 100
- -
$5M - 25M
5
APT's Competitor - Cambium Networks logo

Morgan Kurk

President & CEO

82/100
570
$69.6M
$172.2M

APT VS Cidara

Cidara is APT's #1 rival. Cidara is a Public company that was founded in San Diego, California in 2012. Like APT, Cidara also works within the Biotechnology field. Cidara has 78 more employees vs. APT.

APT VS Seres Therapeutics

Seres Therapeutics is perceived as one of APT's biggest rivals. Seres Therapeutics was founded in 2010, and is headquartered in Cambridge, Massachusetts. Like APT, Seres Therapeutics also operates in the Biotechnology sector. Seres Therapeutics generates $125.3M more revenue vs. APT.

APT VS Axial Therapeutics

Axial Therapeutics is a top competitor of APT. Axial Therapeutics is a Private company that was founded in 2013 in Woburn, Massachusetts. Like APT, Axial Therapeutics also operates in the Biotechnology space. Compared to APT, Axial Therapeutics has 48 more employees.

Frequently Asked Questions about APT

  1. Who are APT's top competitors?

    APT's top 3 competitors are Cidara, Seres Therapeutics, Axial Therapeutics.
  2. Who is similar to APT?

    Cidara is the most similar to APT. Seres Therapeutics and Axial Therapeutics are also similar to APT.
  1. Are APT and Cidara competitors?

    Yes, Cidara is one of APT’s top competitors.